Join to View Full Profile
330 Mt Auburn StCambridge, MA 02138
Phone+1 617-661-4600
Fax+1 617-576-2523
Dr. Vaz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am an incoming Pulmonary and Critical Care Medicine Fellow at Yale School of Medicine. I am finishing my Internal Medicine residency at Mount Auburn Hospital in Cambridge, MA, where I care for patients with a wide range of complex medical conditions and developed a strong interest in pulmonary and critical care. My previous research at Dana-Farber Cancer Institute and Brigham and Women’s Hospital focused on how tumor genomics shape responses to immunotherapy in non-small cell lung cancer. I’ve been fortunate to contribute to several impactful publications. I’m also passionate about Interventional Pulmonology, a field that combines medical research and applies it directly to patient care. I’m excited to continue growing as a physician and researcher in this next career chapter.
Education & Training
FCMMGClass of 2020
Certifications & Licensure
MA State Medical License 2022 - 2025
Publications & Presentations
PubMed
- Non-recurrent mutations and copy number changes predominate pituitary adenoma genomes.Dipika R Mohan, Ticiana Paes, Jacobo Buelvas Mebarak, David M Meredith, Beatriz Soares
European Journal of Endocrinology. 2025-04-29 - Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non-Small Cell ...Federica Pecci, Rohit Thummalapalli, Stephanie L Alden, Biagio Ricciuti, Joao V Alessi
Clinical Cancer Research. 2025-04-18 - Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) Pati...Adriana P C Barrichello, Arielle Elkrief, Biagio Ricciuti, Teja Ganta, Thomas U Marron
Clinical Lung Cancer. 2025-02-04
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
